OncoResponse

oncoresponseinc.com

OncoResponse is a biotech company developing antibody-based cancer immunotherapies.

Facts

HQ
Seattle, US
Sectors
Research
Founded
2016
Type
Corporation Seattle business license
Employees
9
Registered name
OncoResponse Inc Seattle business license
Stage
Series D
Members see funding amounts.
.

Is this your organization? Claim it

Juno Therapeutics’ 2013 launch spurred Seattle cell-therapy boom after $300M+ raise and $9B+ 2018 sale to Celgene

Juno Therapeutics, founded in 2013, accelerated cell therapy development by raising over $300 million, going public within a year, and selling to Celgene for more than $9 billion in 2018, and its alumni spawned many Seattle-area biotech startups. The company’s success attracted capital, validated Seattle as a cellular and gene therapy hub, and influenced the region’s biotech entrepreneurship and leadership.

See all 5 stories, episodes and videos about OncoResponse.

People

  • Clifford Stocks
    Clifford Stocks Founder, Executive Officer, Director, Chief Executive Officer

Online